NCT06879340
- Conditions
- B-Cell Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
- Locations
-
- University of Kansas Cancer Center Westwood, Kansas, United States
Clinical trial condition
Burkitt Lymphoma
Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.
701 public trials
113 recruiting studies
Burkitt Lymphoma trial results
NCT05794880
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Anemia, +44 more
- Locations
-
- Children's Wisconsin Milwaukee, Wisconsin, United States
NCT07564453
- Conditions
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT07048535
- Conditions
- B-cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT07097363
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +23 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT04491370
- Conditions
- B-cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +27 more
- Locations
-
- New York Medical Center Valhalla, New York, United States
NCT07523555
- Conditions
- BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +50 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
NCT06208735
- Conditions
- B-cell Acute Lymphoblastic Leukemia, B-cell Leukemia, B-cell Lymphoma, +28 more
- Locations
-
- Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
- Alberta Children's Hospital Calgary, Alberta, Canada
- Vancouver General Hospital Vancouver, British Columbia, Canada
- BC Children's Hospital Vancouver, British Columbia, Canada
Recruiting
NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
NCT07502118
- Conditions
- Burkitt Lymphoma, Cytokine Release Syndrome, DNA Virus Infections, +29 more
- Locations
-
- Ankara Bilkent City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Ankara Etlik City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology Ankara, Turkey (Türkiye)
- University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
NCT05674175
- Conditions
- B Lineage Lymphoblastic Lymphoma, B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
- Locations
-
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States